GuidelineClinical and molecular hepatology2013
KASL clinical practice guidelines: management of nonalcoholic fatty liver disease.
Guideline in Clinical and molecular hepatology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
56 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- NASH/Liver Fibrosis Prevalence and Incidence of Nonliver Comorbidities among People with NAFLD and Incidence of NAFLD by Metabolic Comorbidities: Lessons from South Korea.Digestive diseases (Basel, Switzerland) · 2021Pooled it
- Clinical guidelines of non-alcoholic fatty liver disease: A systematic review.World journal of gastroenterology · 2016Pooled it
- Genome-wide association study of metabolic dysfunction-associated fatty liver disease in a Korean population.Scientific reports · 2024Article
- Exploring public interest in gut microbiome dysbiosis, NAFLD, and probiotics using Google Trends.Scientific reports · 2024Article
- Barriers to care linkage and educational impact on unnecessary MASLD referrals.Frontiers in medicine · 2024Article
- Neck Circumference as a Predictor of Insulin Resistance in People with Non-alcoholic Fatty Liver Disease.Journal of obesity & metabolic syndrome · 2023Article
- New Insights into the Pathogenesis of Metabolic-Associated Fatty Liver Disease (MAFLD): Gut-Liver-Heart Crosstalk.Nutrients · 2023Review
- Associations of physical activity domains and muscle strength exercise with non-alcoholic fatty liver disease: a nation-wide cohort study.Scientific reports · 2023Article
- Fatty Liver and Risk of Head and Neck Cancer in Type 2 Diabetes Mellitus: A Nationwide Cohort Study.Cancers · 2023Article
- Association between serum uric acid level and non-alcoholic fatty liver disease in Koreans.Asian biomedicine : research, reviews and news · 2022Article
- Association between severe hepatic steatosis examined by Fibroscan and the risk of high-risk colorectal neoplasia.PloS one · 2022Article
- Non-alcoholic/Metabolic-Associated Fatty Liver Disease andFrontiers in medicine · 2022Article
- Different Performance of Liver Stiffness Measurement According to Etiology and Outcome for the Prediction of Liver-Related Events.Digestive diseases and sciences · 2021Article
- Impact of nonalcoholic fatty liver disease on the risk of metachronous colorectal neoplasia after polypectomy.The Korean journal of internal medicine · 2021Article
- Effect of Korea red ginseng on nonalcoholic fatty liver disease: an association of gut microbiota with liver function.Journal of ginseng research · 2021Article
- Hepatocellular Carcinoma in Korea: an Analysis of the 2015 Korean Nationwide Cancer Registry.Journal of liver cancer · 2021Article
- Nutritional Approach Targeting Gut Microbiota in NAFLD-To Date.International journal of environmental research and public health · 2021Review
- Article
- Reenvisioning Traditional to Regenerative Therapeutic Advances in Managing Nonalcoholic Fatty Liver Disease in Diabetes Mellitus.Journal of diabetes research · 2021Review
- Evaluation of the severity of nonalcoholic fatty liver disease through analysis of serum exosomal miRNA expression.PloS one · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.